Kimberly-Clark and Kenvue Shareholders Overwhelmingly Approve Acquisition

Shareholders of Kimberly-Clark Corporation and Kenvue Inc. overwhelmingly approved Kimberly-Clark's proposed acquisition of Kenvue at their respective special stockholder meetings held on January 29, 2026. Preliminary results show approximately 96% of shares present at Kimberly-Clark's meeting voted in favor of issuing shares for the transaction. At Kenvue's meeting, about 99% of votes cast approved the merger agreement, representing roughly 77% of outstanding shares.​

Mike Hsu, Kimberly-Clark's Chairman and CEO, expressed gratitude: "We are grateful to Kimberly-Clark shareholders who voted resoundingly in support of our combination with Kenvue." Kenvue CEO Kirk Perry added, "We thank Kenvue shareholders for their strong support in approving our transaction with Kimberly-Clark."​

The deal aims to create a global health and wellness leader, combining Kimberly-Clark's brands like Huggies, Kleenex, and Kotex with Kenvue's Aveeno, Band-Aid, and Tylenol. Kimberly-Clark holds top market shares in about 70 countries.​

Final results will be certified and filed with the U.S. Securities and Exchange Commission. The acquisition is expected to close in the second half of 2026, subject to regulatory approvals and customary conditions.